WIN Metals secures processing plant option for Radio Gold restart

WIN Metals has secured an option over a modular gravity processing plant, advancing plans to restart…
The Market Online Video

The ASX Today: BHP, Macquarie hit records as energy stocks tumble

The ASX 200 pushed higher as BHP and Macquarie reached record highs, gold stocks rallied and…

1414 Degrees enters space sector with Orbit Boy partnership

14D has developed a new satellite battery technology agreement with European space company Orbit Boy.

Reserve Bank holds rates at 4.35% as inflation battle drags on

The Reserve Bank has left the cash rate unchanged at 4.35%, warning inflation remains too high…
The ASX Today feature image with a red bear (FALL) silhouette beside The Market Link column branding.

The ASX Today: Reserve Bank holds for first time in CY26, markets digest inflation risks

The RBA kept the cash rate unchanged at 4.35% while warning inflation remains too high. The…

Westar secures Northern Territory grant to advance copper hunt at Bunda Creek

Westar Resources has secured Northern Territory government funding for an airborne geophysical survey at its Bunda…
Felix, an automated sperm separation device used in IVF, is grabbing growing international attention.

Memphasys lands national Monash IVF supply deal for Felix system

Memphasys has secured a 12-month exclusive national supply agreement with Monash IVF for its Felix sperm…
The Market Online Video

The ASX Today: Oz market surges to 2-month high as US-Iran deal sparks relief rally

The ASX 200 climbed to a two-month high as hopes of a US-Iran peace deal sent…
Global trade disruption concept with container ships blocked from entering or exiting the Strait of Hormuz. Maritime blockade and geopolitical tension affecting international supply chain and shipping routes.

Markets rally, ASX surges as US-Iran strike preliminary deal to reopen Strait of Hormuz

Australian shares rallied after the US and Iran confirmed a landmark ceasefire agreement, lifting miners, banks…

Paradigm clears key Phase 3 hurdle as osteoarthritis trial enrolment completes

Paradigm Biopharmaceuticals has completed enrolment in its pivotal Phase 3 osteoarthritis trial, with top-line results due…